April 4, 2024 News by Lindsey Shapiro, PhD Improved fatty acid profiles tied to cognitive gains with two MS diets The Swank and Wahls diets, which are used by people with multiple sclerosis (MS), were associated with improvements in cognition and fatty acid blood profiles in relapsing-remitting MS (RRMS) patients, according to new analyses from the WAVES trial. Changes in omega-3 fatty acids after about three months correlated…
November 22, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Neural Sleeve, Supplements, Ocrevus, Cladribine Injection Wearable āNeural Sleeveā Counters Foot Drop, Aids Mobility in Study This is a neat concept, described by the manufacturer as a lightweight sleeve on the lower leg that predicts the movement a leg is about to make. Then it sends a signal to the muscles to help lift that…
August 15, 2019 News by Ana Pena PhD Specific Fats in Cerebrospinal Fluid of MS Patients May Be Telling Markers of Disease, Study Suggests Testing for the types of fat (lipid) molecules present in the cerebrospinal fluid (CSF) of people with multiple sclerosis (MS) may be a very useful way to diagnose and monitor the disease, a study suggests. “MS patients present a different lipid profile at the time of diagnosis” than…
March 14, 2019 News by Jose Marques Lopes, PhD Fatty Acid Pentanoate May Be Effective Treatment for MS, Other Autoimmune Diseases, Mouse Study Suggests Increased production of an anti-inflammatory molecule called interleukin (IL)-10, and suppression of a subtype of immune T-cells, may mean that a fatty acid called pentanoate is effective against inflammatory and autoimmune diseases such as multiple sclerosis (MS), according to new research in mice. The study, āThe…
February 25, 2019 News by Alberto Molano, PhD Study Indicates Possible Correlation Between Nutritional Status, MS Multiple sclerosis (MS) patients eat a more limited diet, with a lower average of 31 nutrients, including zinc, thiamin, and iron, when compared with healthy controls, a study shows. Blood tests also showed that MS patients had significantly lower iron levels, a different fatty acid composition in their red blood…
March 6, 2018 News by Diogo Pinto High Fish Consumption May Be Key to Lowering Risk of Developing MS Eating fish once a week, or one to three times per month along with taking daily fish oil supplements, may help lower the risk of developing multiple sclerosis (MS), a preliminary study shows. These findings suggest that the omega-3 fatty acids in fish like salmon, tuna and shrimp may…
August 25, 2017 News by Patricia Silva, PhD Omega-3 Fatty Acids May Reduce Inflammation by Changing Immune Cell Processes, Study Suggests Omega-3 fatty acids might reduce inflammatory processes by boosting a mechanism that cleans out dysfunctional or unnecessary proteins in a certain type of immune cells, according to a study published in the journal Autophagy. These insights indicate that omega-3 supplements might be beneficial for certain multiple sclerosis (MS) patients,…
February 24, 2017 News by Patricia Silva, PhD #ACTRIMS2017 – Some Fatty Acids in Diet Help, Others Hurt Immune System, Study Reports Short-chain dietary fatty acids, such as propionate, drive the production of regulatory immune T-cells in patients with multiple sclerosis (MS), while long-chain acids promote T-cells that are involved in inflammatory processes. Since the beneficial fatty acids are safe and can be obtained as over-the-counter dietary supplements, researchers suggest they could…
October 23, 2015 News by Patricia Silva, PhD Autoimmune Flare-Ups in Multiple Sclerosis May Be Influenced by Dietary Fat Results from a recent study published in the journal Immunity indicate thatĀ dietary fat has an influence in the duration and severity of autoimmune flare-ups in a mouse model of multiple sclerosis. The team of researchers also showed that adjusting the length of the fatty acids consumed by…
October 13, 2015 News by Patricia Silva, PhD Insights into Promising MS Therapies at Late Breaking News Session, ECTRIMS 2015 A session titled āLate Breaking Newsā was featured at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Oct. 7-10, 2015, in Barcelona, Spain. At this session, Prof. Xavier Montalban from the Hospital Vall d’Hebron University in Barcelona presented data on the promising Genentech/Roche…